ALSA Ventures

Working with tomorrow’s breakthroughs today

We invest in biotechnology companies passionate about bringing novel therapies to patients

View investments

ALSA Ventures is a London based international life science investor focused on novel therapeutics.

With a background in the pharmaceutical, biotechnology and CRO industries, our investment team brings a wealth of practical experience to portfolio, companies from spinoff to public market listing.

Learn more
“We believe that European innovation in life sciences has the power to create valuable businesses with global impact. That, combined with the investment market opportunity in Europe, is the driver for ALSA Ventures, a Europe focused biotechnology fund manager.”

Our Approach

Our investment approach is primarily focused around therapeutics. We look for novel drugs and modalities in a wide variety of disease areas, and invest across the spectrum of drug development. We are equally comfortable in company formation, as we are in participating in syndicates with co-investors.

Learn More

Our portfolio

Axovia Therapeutics
Vantage Biosciences
Promatix
Montis Biosciences
Epsilogen
Oxford BioTherapeutics
View investments